Effects of Cardiovascular Risk Factor Variability on Health Outcomes

被引:28
|
作者
Lee, Seung-Hwan [1 ]
Kim, Mee Kyoung [2 ]
Rhee, Eun-Jung [3 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Seoul St Marys Hosp, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Yeouido St Marys Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Sch Med, 29 Saemunan Ro, Seoul 03181, South Korea
关键词
Variability; Glucose; Blood pressure; Body weight; Lipids; Mortality; Cardiovascular diseases; TO-VISIT VARIABILITY; SYSTOLIC BLOOD-PRESSURE; LIPOPROTEIN CHOLESTEROL VARIABILITY; SUBTILISIN/KEXIN TYPE 9; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BODY-WEIGHT; MYOCARDIAL-INFARCTION; GLYCEMIC VARIABILITY; MONOCLONAL-ANTIBODY;
D O I
10.3803/EnM.2020.35.2.217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Innumerable studies have suggested "the lower, the better" for cardiovascular risk factors, such as body weight, lipid profile, blood pressure, and blood glucose, in terms of health outcomes. However, excessively low levels of these parameters cause health problems, as seen in cachexia, hypoglycemia, and hypotension. Body weight fluctuation is related to mortality, diabetes, obesity, cardiovascular disease, and cancer, although contradictory findings have been reported. High lipid variability is associated with increased mortality and elevated risks of cardiovascular disease, diabetes, end-stage renal disease, and dementia. High blood pressure variability is associated with increased mortality, myocardial infarction, hospitalization, and dementia, which may be caused by hypotension Furthermore, high glucose variability, which can be measured by continuous glucose monitoring systems or self-monitoring of blood glucose levels, is associated with increased mortality, microvascular and macrovascular complications of diabetes, and hypoglycemic events, leading to hospitalization. Variability in metabolic parameters could be affected by medications, such as statins, antihypertensives, and hypoglycemic agents, and changes in lifestyle patterns. However, other mechanisms modify the relationships between biological variability and various health outcomes. In this study, we review recent evidence regarding the role of variability in metabolic parameters and discuss the clinical implications of these findings.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
  • [1] Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment
    Ali, S.
    Santomauro, D.
    Ferrari, A. J.
    Charlson, F.
    [J]. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2023, 32
  • [2] Blood pressure variability as a cardiovascular risk factor
    Parat, G.
    [J]. JOURNAL OF HYPERTENSION, 2008, 26 : S534 - S534
  • [3] Lipid Variability as a Risk Factor of Major Adverse Cardiovascular Outcomes. MetaAnalysis of Observational Studies
    Rueda-Ochoa, Oscar L.
    Zambrano, Laura Valentina V. Vega
    Osma, Juan Camilo R. Gomez
    [J]. CIRCULATION, 2023, 148
  • [4] Glucose variability: a new risk factor for cardiovascular disease
    Belli, Martina
    Bellia, Alfonso
    Sergi, Domenico
    Barone, Lucy
    Lauro, Davide
    Barilla, Francesco
    [J]. ACTA DIABETOLOGICA, 2023, 60 (10) : 1291 - 1299
  • [5] Blood pressure variability: a confounder and a cardiovascular risk factor
    Dimitris E Papadogiannis
    Athanase D Protogerou
    [J]. Hypertension Research, 2011, 34 : 162 - 163
  • [6] Glucose variability: a new risk factor for cardiovascular disease
    Martina Belli
    Alfonso Bellia
    Domenico Sergi
    Lucy Barone
    Davide Lauro
    Francesco Barillà
    [J]. Acta Diabetologica, 2023, 60 : 1291 - 1299
  • [7] Blood pressure variability: a confounder and a cardiovascular risk factor
    Papadogiannis, Dimitris E.
    Protogerou, Athanase D.
    [J]. HYPERTENSION RESEARCH, 2011, 34 (02) : 162 - 163
  • [8] Blood pressure variability: cardiovascular risk integrator or independent risk factor?
    Blacher, J.
    Safar, M. E.
    Ly, C.
    de Edelenyi, F. Szabo
    Hercberg, S.
    Galan, P.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2015, 29 (02) : 122 - 126
  • [9] Blood pressure variability: cardiovascular risk integrator or independent risk factor?
    J Blacher
    M E Safar
    C Ly
    F Szabo de Edelenyi
    S Hercberg
    P Galan
    [J]. Journal of Human Hypertension, 2015, 29 : 122 - 126
  • [10] Blood pressure variability in hypertension - A possible cardiovascular risk factor
    Kario, K
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (11) : 1075 - 1076